Page last updated: 2024-08-23

mifepristone and Hypokalemia

mifepristone has been researched along with Hypokalemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allolio, B; Bouchard, P; Brue, T; Castinetti, F; Chanson, P; Conte-Devolx, B; Do Cao, C; Fassnacht, M; Hahner, S; Johanssen, S; Morange, I; Ouzounian, S; Picó, A; Terzolo, M; Young, J1
Azroyan, A; Bloch-Faure, M; Crambert, G; Doucet, A; Edwards, A; Elabida, B; Fodstad, H; Meneton, P; Salhi, A1
Brue, T; Castinetti, F; Conte-Devolx, B1
Doraiswamy, PM; Ferris, S; Pomara, N; Tun, H1

Reviews

1 review(s) available for mifepristone and Hypokalemia

ArticleYear
The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.
    Current opinion in endocrinology, diabetes, and obesity, 2012, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Blood Pressure; Child, Preschool; Cushing Syndrome; Female; Hormone Antagonists; Humans; Hypokalemia; Male; Middle Aged; Mifepristone; Receptors, Glucocorticoid; Young Adult

2012

Trials

1 trial(s) available for mifepristone and Hypokalemia

ArticleYear
Mifepristone (RU 486) for Alzheimer's disease.
    Neurology, 2002, May-14, Volume: 58, Issue:9

    Topics: Aged; Alzheimer Disease; Anorexia; Cognition; Double-Blind Method; Drug Eruptions; Fatigue; Female; Headache; Hormone Antagonists; Humans; Hypokalemia; Male; Mifepristone; Neuropsychological Tests; Pilot Projects; Receptors, Glucocorticoid; Treatment Outcome

2002

Other Studies

2 other study(ies) available for mifepristone and Hypokalemia

ArticleYear
Merits and pitfalls of mifepristone in Cushing's syndrome.
    European journal of endocrinology, 2009, Volume: 160, Issue:6

    Topics: Adrenal Insufficiency; Adult; Cushing Syndrome; Female; Humans; Hypertension; Hypokalemia; Male; Middle Aged; Mifepristone; Retrospective Studies; Young Adult

2009
Chronic potassium depletion increases adrenal progesterone production that is necessary for efficient renal retention of potassium.
    Kidney international, 2011, Volume: 80, Issue:3

    Topics: Adrenal Glands; Aldosterone; Analysis of Variance; Animals; Cell Line; Chronic Disease; Corticosterone; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; H(+)-K(+)-Exchanging ATPase; Hormone Antagonists; Humans; Hypokalemia; Kidney; Male; Mice; Mice, Knockout; Mifepristone; Models, Biological; Potassium, Dietary; Progesterone; Receptors, Progesterone; Sodium, Dietary; Time Factors; Up-Regulation

2011